Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Table 7

Risk factors of metabolic syndrome in subjects with non-fatty liver disease by multivariate analysis.

	Odds ratio	95% confidence interval	P value
All subjects
BMI	1.371	1.346–1.397	<0.001
Age	1.042	1.038–1.046	<0.001
ALT	1.007	1.004–1.010	<0.001
GGT	1.004	1.002–1.006	<0.001
Platelet	1.001	1.001–1.002	0.001
Male gender	4.071	3.628–4.568	<0.001
Female subjects
BMI	1.382	1.339–1.426	<0.001
Age	1.080	1.070–1.089	<0.001
ALT	1.010	1.005–1.015	<0.001
Platelet	1.002	1.000–1.003	0.028
Male subjects
BMI	1.351	1.320–1.383	<0.001
Age	1.032	1.028–1.037	<0.001
ALT	1.005	1.001–1.009	0.021
GGT	1.005	1.003–1.007	<0.001
Platelet	1.002	1.001–1.003	0.002

BMI, body mass index; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase.